{
    "2020-09-21": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dips",
                        "Broader Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma ETFs to Benefit from Lilly's Coronavirus Antibody Progress",
                "features": {
                    "keywords": [
                        "Pharma ETFs",
                        "Lilly",
                        "Coronavirus Antibody",
                        "Progress"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly's Olumiant Gets CHMP Nod for Eczema Label Expansion",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Olumiant",
                        "CHMP Nod",
                        "Eczema",
                        "Label Expansion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain.",
                "features": {
                    "keywords": [
                        "Anticancer Drug",
                        "Team-Ups",
                        "Promise",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Eli Lillyâ€™s Verzenio Treatment Lowers Breast Cancer Recurrence By 25%",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Verzenio",
                        "Breast Cancer",
                        "Recurrence",
                        "25%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}